查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1344467

阻垢剂市场:各类型，各方法，各最终用途产业:全球机会分析与产业预测，2023-2032年

Antiscalants/Scale Inhibitors Market By Type, By Method, By End-Use Industry : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 382 Pages | 商品交期: 2-3个工作天内

价格

根据Allied Market Research最新发布的研究报告 "阻垢剂/阻垢剂市场" ，2022年阻垢剂/阻垢剂市场价值将达到35亿美元，预计2023年至2032年将持续成长。预计年复合成长率为 4.7%，到 2032 年将达到 55 亿美元。

阻垢剂/阻垢剂市场-IMG1

阻垢剂用于防止工业水系统（例如锅炉和冷却水塔）中形成矿物质水垢。钙、镁和二氧化硅等矿物质沉积在表面，促使结垢、腐蚀并降低效率。防喷剂抑制晶体生长和团聚，依化学成分分类，如羧酸盐、磺酸盐、膦酸盐和氟化物。这些试剂要么抑制晶体生长，要么与水中的矿物离子结合以抑制水垢形成。

对石油和天然气的需求不断增加，迫使其生产进入更恶劣的环境，其中生产过程中使用的水含盐量更高，并且含有更高含量的结垢矿物质。因此，更容易发生结垢，需要更多的阻垢剂。阻垢剂是一种经济高效的解决方案，可防止结垢并减少对更昂贵且耗时的清洁方法的需求。它还有助于延长设备使用寿命、降低维护和更换成本、提高生产效率并减少停机时间。防误算剂可抑制与水接触的表面上矿物质沉积物的生长和沈淀，从而防止水垢形成。这是透过隔离矿物离子以防止反应和水垢形成，或透过改变矿物的晶体结构以使其不易形成水垢来实现的。它用于逆渗透（RO）薄膜系统、冷却水处理、海水淡化、石油和天然气生产、工业锅炉等，所有这些因素都在推动阻垢剂市场的成长。

但是，它可能无法有效对抗所有类型的水垢和沈积物，并且其有效性在高温应用中可能受到限制。与水处理系统中其他化学品的兼容性问题也会降低其有效性或促使其他问题。此外，如果处理和处置不当，一些抗硫剂会对环境产生负面影响，处理后会在水中留下化学残留物。这些因素都限制了阻垢剂市场的成长。

目录

第1章 简介

第2章 摘要整理

第3章 市场概要

  • 市场定义和范围
  • 主要调查结果
    • 影响要素
    • 主要的投资机会
  • 波特的五力分析
  • 市场动态
    • 促进因素
      • 石油和天然气产业对阻垢剂的需求成长
      • 防止水垢形成的经济有效的解决方案
    • 抑制因素
      • 使用阻垢剂的缺点
    • 机会
      • 水处理业对阻垢剂的需求不断增加
  • COVID-19对市场的影响分析
  • 价值链分析
  • 价格分析
  • 法规指南
  • 主要法规分析
  • 专利形势

第4章 阻垢剂市场:各类型

  • 羧酸盐
  • 磺酸盐酸盐
  • 磷酸酯
  • 氟化物
  • 其他

第5章 阻垢剂市场:各方法

  • 阈值阻碍
  • 结晶改性
  • 分散
  • 其他

第6章 阻垢剂市场:各最终用途产业

  • 石油、天然气
  • 用水和污水处理
  • 电力·建设
  • 化学工业
  • 纸浆·造纸
  • 矿业
  • 其他

第7章 阻垢剂市场:各地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 南美·中东·非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他地区

第8章 竞争情形

  • 简介
  • 主要成功策略
  • 主要10企业的产品製图
  • 竞争仪表板
  • 竞争热图
  • 主要企业的定位，2022年

第9章 企业简介

  • Clariant AG
  • Kemira Oyg
  • General Electric
  • Dow Inc.
  • Ashland
  • Avista Technologies
  • Solenis
  • Solvay
  • Lenntech B.V.
  • BASF SE
Product Code: A11581

According to a new report published by Allied Market Research, titled, "Antiscalants/Scale Inhibitors Market," The antiscalants/scale inhibitors market was valued at $3.5 billion in 2022, and is estimated to reach $5.5 billion by 2032, growing at a CAGR of 4.7% from 2023 to 2032.

Antiscalants/Scale Inhibitors Market - IMG1

Antiscalants are used to prevent the formation of mineral scales in industrial water systems such as boilers and cooling towers. Minerals such as calcium, magnesium, and silica are deposited on surfaces causing fouling, corrosion, and decreased efficiency. Antiscalants inhibit crystal growth and aggregation and are classified according to their chemical composition, which includes carboxylates, sulfonates, phosphonates, fluorides, and others. They accomplish this by either interfering with crystal growth or binding to mineral ions in the water which reduce the scale formation.

The increase in demand for oil and gas led to its production and moving to more challenging environments where the water used in the processes becomes more saline and contains higher levels of scaling minerals. This makes scaling more likely and antiscalants more necessary. Antiscalants are a cost-effective solution for preventing scale formation and reducing the need for more expensive and time-consuming cleaning methods. Antiscalants also help to extend the life of equipment, reduce maintenance and replacement costs, improve production efficiency, and reduce downtime. Antiscalants inhibit the growth and precipitation of mineral deposits on surfaces that come into contact with water, which helps to prevent the formation of scale. They achieve this by either sequestering the mineral ions, which prevents them from reacting and forming scale or by changing the crystal structure of the minerals, which makes it more difficult for them to form scale. It is used in reverse osmosis (RO) membrane systems, cooling water treatment, desalination, oil and gas production, and industrial boilers.All these factors drive the growth of the antiscalants market.

However, antiscalants may not be effective against all types of scales or deposits and their effectiveness can be limited in high-temperature applications. Compatibility issues with other chemicals in water treatment systems can also reduce their effectiveness or cause other problems. Additionally, some antiscalants may have negative environmental impacts if not handled or disposed of properly, and residual chemicals may remain in the water after treatment. These factors hinder the growth of the antiscalants market.

The antiscalants market analysis is segmented on the basis of type, method, end-use industry, and region.

By type, the market is segmented into carboxylate, sulfonates, phosphonates, fluorides, and others. The sulfonates segment is anticipated to grow at the fastest CAGR of 5.1% during the forecast period. The rise in the need for sustainable water treatment solutions, increase in industrialization, and urbanization in emerging economies such as China and India are driving the demand for phosphonates antiscalants. The inadequate access to water and sanitation results in water-borne illnesses which drive the growth of phosphonates antiscalants in the desalination process.

By method, the market is categorized into threshold inhibition, crystal modification, dispersion, and others. The threshold inhibition segment is anticipated to grow at the fastest CAGR of 5.0% during the forecast period. Threshold inhibition is an effective and cost-efficient method, which increases the demand for antiscalants. These antiscalants have several advantages over traditional ones as they produce less waste, are environmentally friendly, and are free from harmful phosphates. All these factors anticipated new growth opportunities for threshold inhibition antiscalants during the forecast period.

By end-use industry, the market is fragmented into oil & gas, water & wastewater treatment, power & construction, chemical industry, pulp & paper, mining, and others. The water and wastewater segment is anticipated to grow at the fastest CAGR of 5.3% during the forecast period. As the demand for oil and gas grows, companies are using antiscalants to prevent scaling and maintain optimal production levels. The use of unconventional oil and gas extraction methods and offshore drilling create opportunities for antiscalants. In addition to that, antiscalants help the industry to reduce its environmental impact. As a result, the demand for antiscalants in the oil and gas industry is expected to increase during the forecast period.

By region, the antiscalants market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The Asia-Pacific region witnessed the fastest CAGR growth during the forecast period. The rise in population in Asia-Pacific increases the demand for water treatment solutions in that antiscalants are used to maintain clean drinking water. Rapid industrialization in countries such as China, India, and Indonesia is driving the demand for antiscalants in various industries such as power generation, oil and gas, and mining to prevent scale buildup and maintain efficient operations.

Key players in the antiscalants industry include: Kemira Oyg, Clariant AG, General Electric, Dow Inc., Ashland, Avista Technologies, Solvay, Solenis, and Lenntech B.V.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the antiscalants/scale inhibitors market analysis from 2022 to 2032 to identify the prevailing antiscalants/scale inhibitors market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the antiscalants/scale inhibitors market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global antiscalants/scale inhibitors market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Carboxylate
  • Sulfonates
  • Phosphonates
  • Fluorids
  • Others

By Method

  • Threshold Inhibition
  • Crystal Modification
  • Dispersion
  • Others

By End-Use Industry

  • Pulp and Paper
  • Mining
  • Others
  • Oil and Gas
  • Water and Wastewater Treatment
  • Power and Construction
  • Chemical Industry

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Ashland
    • Avista Technologies
    • BASF SE
    • Clariant AG
    • Dow Inc.
    • General Electric
    • Kemira Oyg
    • Lenntech B.V.
    • Solenis
    • Solvay

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growth in demand for antiscalants in oil and gas industry
      • 3.4.1.2. Cost-effective solution for preventing scale formation
    • 3.4.2. Restraints
      • 3.4.2.1. Disadvantages associated with the use of antiscalants
    • 3.4.3. Opportunities
      • 3.4.3.1. Rising demand for antiscalants in the water treatment industry
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Value Chain Analysis
  • 3.7. Pricing Analysis
  • 3.8. Regulatory Guidelines
  • 3.9. Key Regulation Analysis
  • 3.10. Patent Landscape

CHAPTER 4: ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Carboxylate
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Sulfonates
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Phosphonates
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Fluorids
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Threshold Inhibition
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Crystal Modification
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Dispersion
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Oil and Gas
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Water and Wastewater Treatment
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Power and Construction
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Chemical Industry
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country
  • 6.6. Pulp and Paper
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by region
    • 6.6.3. Market share analysis by country
  • 6.7. Mining
    • 6.7.1. Key market trends, growth factors and opportunities
    • 6.7.2. Market size and forecast, by region
    • 6.7.3. Market share analysis by country
  • 6.8. Others
    • 6.8.1. Key market trends, growth factors and opportunities
    • 6.8.2. Market size and forecast, by region
    • 6.8.3. Market share analysis by country

CHAPTER 7: ANTISCALANTS/SCALE INHIBITORS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Method
    • 7.2.4. Market size and forecast, by End-Use Industry
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Method
      • 7.2.5.1.4. Market size and forecast, by End-Use Industry
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Method
      • 7.2.5.2.4. Market size and forecast, by End-Use Industry
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Method
      • 7.2.5.3.4. Market size and forecast, by End-Use Industry
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Method
    • 7.3.4. Market size and forecast, by End-Use Industry
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Method
      • 7.3.5.1.4. Market size and forecast, by End-Use Industry
      • 7.3.5.2. UK
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Method
      • 7.3.5.2.4. Market size and forecast, by End-Use Industry
      • 7.3.5.3. France
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Method
      • 7.3.5.3.4. Market size and forecast, by End-Use Industry
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Method
      • 7.3.5.4.4. Market size and forecast, by End-Use Industry
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Method
      • 7.3.5.5.4. Market size and forecast, by End-Use Industry
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Method
      • 7.3.5.6.4. Market size and forecast, by End-Use Industry
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Method
    • 7.4.4. Market size and forecast, by End-Use Industry
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Method
      • 7.4.5.1.4. Market size and forecast, by End-Use Industry
      • 7.4.5.2. India
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Method
      • 7.4.5.2.4. Market size and forecast, by End-Use Industry
      • 7.4.5.3. Japan
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Method
      • 7.4.5.3.4. Market size and forecast, by End-Use Industry
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Method
      • 7.4.5.4.4. Market size and forecast, by End-Use Industry
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Method
      • 7.4.5.5.4. Market size and forecast, by End-Use Industry
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by Method
      • 7.4.5.6.4. Market size and forecast, by End-Use Industry
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Method
    • 7.5.4. Market size and forecast, by End-Use Industry
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Method
      • 7.5.5.1.4. Market size and forecast, by End-Use Industry
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Method
      • 7.5.5.2.4. Market size and forecast, by End-Use Industry
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Method
      • 7.5.5.3.4. Market size and forecast, by End-Use Industry
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Method
      • 7.5.5.4.4. Market size and forecast, by End-Use Industry

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Clariant AG
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Kemira Oyg
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. General Electric
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Dow Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Ashland
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Avista Technologies
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Solenis
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Solvay
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Lenntech B.V.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. BASF SE
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. GLOBAL ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 03. ANTISCALANTS/SCALE INHIBITORS MARKET FOR CARBOXYLATE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. ANTISCALANTS/SCALE INHIBITORS MARKET FOR CARBOXYLATE, BY REGION, 2022-2032 (KILOTON)
  • TABLE 05. ANTISCALANTS/SCALE INHIBITORS MARKET FOR SULFONATES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. ANTISCALANTS/SCALE INHIBITORS MARKET FOR SULFONATES, BY REGION, 2022-2032 (KILOTON)
  • TABLE 07. ANTISCALANTS/SCALE INHIBITORS MARKET FOR PHOSPHONATES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. ANTISCALANTS/SCALE INHIBITORS MARKET FOR PHOSPHONATES, BY REGION, 2022-2032 (KILOTON)
  • TABLE 09. ANTISCALANTS/SCALE INHIBITORS MARKET FOR FLUORIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. ANTISCALANTS/SCALE INHIBITORS MARKET FOR FLUORIDS, BY REGION, 2022-2032 (KILOTON)
  • TABLE 11. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY REGION, 2022-2032 (KILOTON)
  • TABLE 13. GLOBAL ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 15. ANTISCALANTS/SCALE INHIBITORS MARKET FOR THRESHOLD INHIBITION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. ANTISCALANTS/SCALE INHIBITORS MARKET FOR THRESHOLD INHIBITION, BY REGION, 2022-2032 (KILOTON)
  • TABLE 17. ANTISCALANTS/SCALE INHIBITORS MARKET FOR CRYSTAL MODIFICATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. ANTISCALANTS/SCALE INHIBITORS MARKET FOR CRYSTAL MODIFICATION, BY REGION, 2022-2032 (KILOTON)
  • TABLE 19. ANTISCALANTS/SCALE INHIBITORS MARKET FOR DISPERSION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. ANTISCALANTS/SCALE INHIBITORS MARKET FOR DISPERSION, BY REGION, 2022-2032 (KILOTON)
  • TABLE 21. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY REGION, 2022-2032 (KILOTON)
  • TABLE 23. GLOBAL ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 24. GLOBAL ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 25. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OIL AND GAS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 26. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OIL AND GAS, BY REGION, 2022-2032 (KILOTON)
  • TABLE 27. ANTISCALANTS/SCALE INHIBITORS MARKET FOR WATER AND WASTEWATER TREATMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 28. ANTISCALANTS/SCALE INHIBITORS MARKET FOR WATER AND WASTEWATER TREATMENT, BY REGION, 2022-2032 (KILOTON)
  • TABLE 29. ANTISCALANTS/SCALE INHIBITORS MARKET FOR POWER AND CONSTRUCTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 30. ANTISCALANTS/SCALE INHIBITORS MARKET FOR POWER AND CONSTRUCTION, BY REGION, 2022-2032 (KILOTON)
  • TABLE 31. ANTISCALANTS/SCALE INHIBITORS MARKET FOR CHEMICAL INDUSTRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 32. ANTISCALANTS/SCALE INHIBITORS MARKET FOR CHEMICAL INDUSTRY, BY REGION, 2022-2032 (KILOTON)
  • TABLE 33. ANTISCALANTS/SCALE INHIBITORS MARKET FOR PULP AND PAPER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 34. ANTISCALANTS/SCALE INHIBITORS MARKET FOR PULP AND PAPER, BY REGION, 2022-2032 (KILOTON)
  • TABLE 35. ANTISCALANTS/SCALE INHIBITORS MARKET FOR MINING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 36. ANTISCALANTS/SCALE INHIBITORS MARKET FOR MINING, BY REGION, 2022-2032 (KILOTON)
  • TABLE 37. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 38. ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY REGION, 2022-2032 (KILOTON)
  • TABLE 39. ANTISCALANTS/SCALE INHIBITORS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 40. ANTISCALANTS/SCALE INHIBITORS MARKET, BY REGION, 2022-2032 (KILOTON)
  • TABLE 41. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 43. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 44. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 45. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 46. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 47. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 48. NORTH AMERICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 (KILOTON)
  • TABLE 49. U.S. ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. U.S. ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 51. U.S. ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 52. U.S. ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 53. U.S. ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 54. U.S. ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 55. CANADA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. CANADA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 57. CANADA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 58. CANADA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 59. CANADA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 60. CANADA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 61. MEXICO ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. MEXICO ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 63. MEXICO ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 64. MEXICO ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 65. MEXICO ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 66. MEXICO ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 67. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 69. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 70. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 71. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 72. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 73. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 74. EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 (KILOTON)
  • TABLE 75. GERMANY ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 76. GERMANY ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 77. GERMANY ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 78. GERMANY ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 79. GERMANY ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 80. GERMANY ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 81. UK ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 82. UK ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 83. UK ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 84. UK ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 85. UK ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 86. UK ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 87. FRANCE ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. FRANCE ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 89. FRANCE ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 90. FRANCE ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 91. FRANCE ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 92. FRANCE ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 93. SPAIN ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 94. SPAIN ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 95. SPAIN ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 96. SPAIN ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 97. SPAIN ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 98. SPAIN ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 99. ITALY ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. ITALY ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 101. ITALY ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 102. ITALY ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 103. ITALY ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 104. ITALY ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 105. REST OF EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 106. REST OF EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 107. REST OF EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 108. REST OF EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 109. REST OF EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 110. REST OF EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 111. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 112. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 113. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 114. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 115. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 116. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 117. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 118. ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 (KILOTON)
  • TABLE 119. CHINA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 120. CHINA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 121. CHINA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 122. CHINA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 123. CHINA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 124. CHINA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 125. INDIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 126. INDIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 127. INDIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 128. INDIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 129. INDIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 130. INDIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 131. JAPAN ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 132. JAPAN ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 133. JAPAN ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 134. JAPAN ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 135. JAPAN ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 136. JAPAN ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 137. SOUTH KOREA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 138. SOUTH KOREA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 139. SOUTH KOREA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 140. SOUTH KOREA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 141. SOUTH KOREA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 142. SOUTH KOREA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 143. AUSTRALIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 144. AUSTRALIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 145. AUSTRALIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 146. AUSTRALIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 147. AUSTRALIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 148. AUSTRALIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 149. REST OF ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 150. REST OF ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 151. REST OF ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 152. REST OF ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 153. REST OF ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 154. REST OF ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 155. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 156. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 157. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 158. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 159. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 160. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 161. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 162. LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY COUNTRY, 2022-2032 (KILOTON)
  • TABLE 163. BRAZIL ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 164. BRAZIL ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 165. BRAZIL ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 166. BRAZIL ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 167. BRAZIL ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 168. BRAZIL ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 169. SAUDI ARABIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 170. SAUDI ARABIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 171. SAUDI ARABIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 172. SAUDI ARABIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 173. SAUDI ARABIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 174. SAUDI ARABIA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 175. SOUTH AFRICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 176. SOUTH AFRICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 177. SOUTH AFRICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 178. SOUTH AFRICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 179. SOUTH AFRICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 180. SOUTH AFRICA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 181. REST OF LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 182. REST OF LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022-2032 (KILOTON)
  • TABLE 183. REST OF LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 184. REST OF LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022-2032 (KILOTON)
  • TABLE 185. REST OF LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 186. REST OF LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022-2032 (KILOTON)
  • TABLE 187. CLARIANT AG: KEY EXECUTIVES
  • TABLE 188. CLARIANT AG: COMPANY SNAPSHOT
  • TABLE 189. CLARIANT AG: PRODUCT SEGMENTS
  • TABLE 190. CLARIANT AG: PRODUCT PORTFOLIO
  • TABLE 191. KEMIRA OYG: KEY EXECUTIVES
  • TABLE 192. KEMIRA OYG: COMPANY SNAPSHOT
  • TABLE 193. KEMIRA OYG: PRODUCT SEGMENTS
  • TABLE 194. KEMIRA OYG: PRODUCT PORTFOLIO
  • TABLE 195. GENERAL ELECTRIC: KEY EXECUTIVES
  • TABLE 196. GENERAL ELECTRIC: COMPANY SNAPSHOT
  • TABLE 197. GENERAL ELECTRIC: SERVICE SEGMENTS
  • TABLE 198. GENERAL ELECTRIC: PRODUCT PORTFOLIO
  • TABLE 199. DOW INC.: KEY EXECUTIVES
  • TABLE 200. DOW INC.: COMPANY SNAPSHOT
  • TABLE 201. DOW INC.: PRODUCT SEGMENTS
  • TABLE 202. DOW INC.: PRODUCT PORTFOLIO
  • TABLE 203. ASHLAND: KEY EXECUTIVES
  • TABLE 204. ASHLAND: COMPANY SNAPSHOT
  • TABLE 205. ASHLAND: PRODUCT SEGMENTS
  • TABLE 206. ASHLAND: PRODUCT PORTFOLIO
  • TABLE 207. AVISTA TECHNOLOGIES : KEY EXECUTIVES
  • TABLE 208. AVISTA TECHNOLOGIES : COMPANY SNAPSHOT
  • TABLE 209. AVISTA TECHNOLOGIES : PRODUCT SEGMENTS
  • TABLE 210. AVISTA TECHNOLOGIES : PRODUCT PORTFOLIO
  • TABLE 211. SOLENIS: KEY EXECUTIVES
  • TABLE 212. SOLENIS: COMPANY SNAPSHOT
  • TABLE 213. SOLENIS: PRODUCT SEGMENTS
  • TABLE 214. SOLENIS: PRODUCT PORTFOLIO
  • TABLE 215. SOLVAY: KEY EXECUTIVES
  • TABLE 216. SOLVAY: COMPANY SNAPSHOT
  • TABLE 217. SOLVAY: PRODUCT SEGMENTS
  • TABLE 218. SOLVAY: PRODUCT PORTFOLIO
  • TABLE 219. LENNTECH B.V.: KEY EXECUTIVES
  • TABLE 220. LENNTECH B.V.: COMPANY SNAPSHOT
  • TABLE 221. LENNTECH B.V.: PRODUCT SEGMENTS
  • TABLE 222. LENNTECH B.V.: PRODUCT PORTFOLIO
  • TABLE 223. BASF SE: KEY EXECUTIVES
  • TABLE 224. BASF SE: COMPANY SNAPSHOT
  • TABLE 225. BASF SE: PRODUCT SEGMENTS
  • TABLE 226. BASF SE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032
  • FIGURE 03. ANTISCALANTS/SCALE INHIBITORS MARKET,2022-2032
  • FIGURE 04. TOP INVESTMENT POCKETS IN ANTISCALANTS/SCALE INHIBITORS MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL ANTISCALANTS/SCALE INHIBITORS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PRICING ANALYSIS: ANTISCALANTS/SCALE INHIBITORS MARKET 2022 AND 2032
  • FIGURE 12. REGULATORY GUIDELINES: ANTISCALANTS/SCALE INHIBITORS MARKET
  • FIGURE 13. IMPACT OF KEY REGULATION: ANTISCALANTS/SCALE INHIBITORS MARKET
  • FIGURE 14. PATENT ANALYSIS BY COMPANY
  • FIGURE 15. PATENT ANALYSIS BY COUNTRY
  • FIGURE 16. ANTISCALANTS/SCALE INHIBITORS MARKET, BY TYPE, 2022(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR CARBOXYLATE, BY COUNTRY 2022-2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR SULFONATES, BY COUNTRY 2022-2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR PHOSPHONATES, BY COUNTRY 2022-2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR FLUORIDS, BY COUNTRY 2022-2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 22. ANTISCALANTS/SCALE INHIBITORS MARKET, BY METHOD, 2022(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR THRESHOLD INHIBITION, BY COUNTRY 2022-2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR CRYSTAL MODIFICATION, BY COUNTRY 2022-2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR DISPERSION, BY COUNTRY 2022-2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 27. ANTISCALANTS/SCALE INHIBITORS MARKET, BY END-USE INDUSTRY, 2022(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR OIL AND GAS, BY COUNTRY 2022-2032(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR WATER AND WASTEWATER TREATMENT, BY COUNTRY 2022-2032(%)
  • FIGURE 30. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR POWER AND CONSTRUCTION, BY COUNTRY 2022-2032(%)
  • FIGURE 31. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR CHEMICAL INDUSTRY, BY COUNTRY 2022-2032(%)
  • FIGURE 32. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR PULP AND PAPER, BY COUNTRY 2022-2032(%)
  • FIGURE 33. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR MINING, BY COUNTRY 2022-2032(%)
  • FIGURE 34. COMPARATIVE SHARE ANALYSIS OF ANTISCALANTS/SCALE INHIBITORS MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 35. ANTISCALANTS/SCALE INHIBITORS MARKET BY REGION, 2022
  • FIGURE 36. U.S. ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. CANADA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. MEXICO ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. GERMANY ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. UK ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. FRANCE ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SPAIN ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. ITALY ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. REST OF EUROPE ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. CHINA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. INDIA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. JAPAN ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. SOUTH KOREA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. AUSTRALIA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. REST OF ASIA-PACIFIC ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 51. BRAZIL ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 52. SAUDI ARABIA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 53. SOUTH AFRICA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 54. REST OF LAMEA ANTISCALANTS/SCALE INHIBITORS MARKET, 2022-2032 ($MILLION)
  • FIGURE 55. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 56. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 57. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 58. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 59. COMPETITIVE DASHBOARD
  • FIGURE 60. COMPETITIVE HEATMAP: ANTISCALANTS/SCALE INHIBITORS MARKET
  • FIGURE 61. TOP PLAYER POSITIONING, 2022
  • FIGURE 62. CLARIANT: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 63. CLARIANT: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 64. CLARIANT: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 65. KEMIRA OYG: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 66. KEMIRA OYG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. KEMIRA OYG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. GENERAL ELECTRIC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 69. GENERAL ELECTRIC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 70. GENERAL ELECTRIC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 71. DOW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 72. DOW: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 73. DOW: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 74. ASHLAND: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 75. ASHLAND: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 76. SOLVAY: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 77. SOLVAY: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 78. BASF SE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 79. BASF SE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 80. BASF SE: REVENUE SHARE BY REGION, 2022 (%)